V1A and V2 receptors — Drug Target

All drugs that target V1A and V2 receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Vasopressin receptor agonist

Phase 3 pipeline (1)

• Vasopressin administration · Assistance Publique Hopitaux De Marseille · Vasopressin receptor agonist · Cardiovascular
  Vasopressin acts as a potent vasoconstrictor by stimulating V1A receptors on vascular smooth muscle cells, causing blood vessels to constrict.